Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Inotuzumab Ozogamicin”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01055496
What this trial is testing

Study Evaluating Chemotherapy in Combination With Inotuzumab Ozogamicin In Subjects With Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma, B-Cell
Pfizer 103
Large-scale testing (Phase 3)Looking for participantsNCT03959085
What this trial is testing

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

Who this might be right for
B Acute Lymphoblastic LeukemiaB Lymphoblastic LymphomaCentral Nervous System Leukemia+2 more
Children's Oncology Group 5,951
Not applicableActive Not RecruitingNCT07238907
What this trial is testing

A Multi-center Retrospective Study of INO Treating B-ALL

Who this might be right for
Acute Lymphoblastic LeukaemiaAcute Lymphoblastic Leukaemias (ALL)Inotuzumab Ozogamicin+1 more
Ruijin Hospital 102
Not applicableUnknownNCT06025682
What this trial is testing

Retrospective Observational Study on Infective Complications and Outcome of Patients With ALL Treated With INO

Who this might be right for
Acute Lymphoblastic LeukemiaInfectionsBacterial Infections+4 more
Gruppo Italiano Malattie EMatologiche dell'Adulto 158
Large-scale testing (Phase 3)Looking for participantsNCT03150693
What this trial is testing

Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia

Who this might be right for
B Acute Lymphoblastic Leukemia
Alliance for Clinical Trials in Oncology 303
Testing effectiveness (Phase 2)Looking for participantsNCT04747912
What this trial is testing

Study of Chemotherapy-Free Induction Regimen for Ph+ Acute Lymphoblastic Leukemia With Inotuzumab Ozogamicin (InO)

Who this might be right for
Lymphoblastic LeukemiaAcute Lymphoblastic Leukemiaph+ Acute Lymphoblastic Leukemia
University of Chicago 25
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07443488
What this trial is testing

Efficacy and Safety of Olverembatinib Plus Inotuzumab Ozogamicin as First-Line Consolidation Therapy Followed by HSCT in Ph+ ALL

Who this might be right for
HSCTPh+ ALL
Institute of Hematology & Blood Diseases Hospital, China 20
Not applicableStudy completedNCT05597085
What this trial is testing

Patients Who Received Inotuzumab Ozogamicin for B-cell ALL (Acute Lymphoblastic Leukemia) That Occurred Again After the Last Treatment

Who this might be right for
Adult Relapsed/Refractory B Cell Acute Lymphoblastic Leukemia
Pfizer 32
Testing effectiveness (Phase 2)Ended earlyNCT03488225
What this trial is testing

Combination Chemotherapy and Inotuzumab Ozogamicin in Treating Patients With B Acute Lymphoblastic Leukemia

Who this might be right for
Acute Lymphoblastic Leukemia in RemissionB Acute Lymphoblastic LeukemiaB Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative
M.D. Anderson Cancer Center 4
Testing effectiveness (Phase 2)Ended earlyNCT03094611
What this trial is testing

Inotuzumab Ozogamicin in Treating Patients With Relapsed or Refractory CD22 Positive Acute Lymphoblastic Leukemia

Who this might be right for
CD22 PositiveRecurrent Acute Lymphoblastic LeukemiaRefractory Acute Lymphoblastic Leukemia
M.D. Anderson Cancer Center 4
Testing effectiveness (Phase 2)Looking for participantsNCT05645718
What this trial is testing

Study of Pedi-cRIB: Mini-Hyper-CVD With Condensed Rituximab, Inotuzumab Ozogamicin and Blinatumomab (cRIB) for Relapsed Therapy for Pediatric With B-Cell Lineage Acute Lymphocytic Leukemia

Who this might be right for
Leukemia
M.D. Anderson Cancer Center 27
Not applicableActive Not RecruitingNCT06476665
What this trial is testing

Learn About the Safety of BESPONSA Injection in Pediatric Patients With Acute Lymphocytic Leukemia.

Who this might be right for
Acute Lymphocytic Leukemia
Pfizer 10
Not applicableStudy completedNCT04307134
What this trial is testing

Besponsa Post Marketing Surveillance Study

Who this might be right for
Hematologic Malignancy
Pfizer 108
Large-scale testing (Phase 3)Looking for participantsNCT04307576
What this trial is testing

A Treatment Study Protocol for Participants 0-45 Years With Acute Lymphoblastic Leukaemia

Who this might be right for
Leukemia, Acute Lymphoblastic
Mats Heyman 6,430
Testing effectiveness (Phase 2)Looking for participantsNCT06554626
What this trial is testing

Blinatumomab Plus Venetoclax Sequenced With Inotuzumab Ozogamicin in Treating B-ALL

Who this might be right for
Precursor B-Cell Lymphoblastic Leukemia
First Affiliated Hospital of Zhejiang University 20
Not applicableStudy completedNCT04456959
What this trial is testing

InO - A Retrospective Study of UK Patients With Leukaemia

Who this might be right for
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Pfizer 28
Testing effectiveness (Phase 2)Study completedNCT01562990
What this trial is testing

Phase Ib/II Study of the Efficacy and Safety of the R-CMC544/R-GEMOX Combination in Diffuse Lage B-cell Lymphoma at First or Second Relapse

Who this might be right for
Diffuse Large B-Cell Lymphoma
The Lymphoma Academic Research Organisation 11
Post-approval studies (Phase 4)Study completedNCT05687032
What this trial is testing

Inotuzumab Ozogamicin in Chinese Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia

Who this might be right for
Acute Lymphoblastic Leukemia
Pfizer 44
Testing effectiveness (Phase 2)Study completedNCT00868608
What this trial is testing

Study Evaluating Inotuzumab Ozogamicin (CMC-544) In Indolent Non-Hodgkins Lymphoma

Who this might be right for
Lymphoma
Pfizer 81
Testing effectiveness (Phase 2)WithdrawnNCT03851081
What this trial is testing

Inotuzumab Ozogamicin and Vincristine Sulfate Liposome in Treating Patients With Relapsed or Refractory CD22+ B-cell Acute Lymphoblastic Leukemia

Who this might be right for
Allogeneic Hematopoietic Stem Cell Transplantation RecipientBlasts 5 Percent or More of Bone Marrow Nucleated CellsBlasts 5 Percent or More of Peripheral Blood White Cells+5 more
Roswell Park Cancer Institute
Next Page